CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
97 hedge funds and large institutions have $154M invested in Concert Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less call options, than puts
Call options by funds: $17K | Put options by funds: $24K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
97
Holding in Top 10
1
Calls
$17K
Puts
$24K
Top Buyers
| 1 | +$3.44M | |
| 2 | +$1.94M | |
| 3 | +$1.31M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.18M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$752K |
Top Sellers
| 1 | -$7.53M | |
| 2 | -$3.18M | |
| 3 | -$1.65M | |
| 4 |
Morgan Stanley
New York
|
-$1.29M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.29M |